ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

September 25, 1998

Named VP, Health sciences At UNM

February 11, 1994

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989